Related Experiment Video
Updated: Aug 9, 2026

Using Immunofluorescence to Detect PM2.5-induced DNA Damage in Zebrafish Embryo Hearts
Published on: February 15, 2021
Metabolic Profiling Reveals PM2.5- and PM10-Induced Vitamin and Oxidative Stress Pathway Alterations Associated with
Chamnan Yibcharoenporn1, Chanon Jakakul1, Meng Chieh Yang2
1Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bang Phli, Samut Prakarn 10540, Thailand.
Abstract:
Particulate matter (PM) is a global air pollutant causing respiratory pathology and systemic effects through bloodstream distribution, including placental transfer that potentially disrupts fetal development. Zebrafish, with rapid development and 82% orthology to human genes, provide an excellent model for studying the developing embryo. This study investigated the effects of PM2.5 and PM10 at 500 and 1000 μg/mL during embryogenesis (4-50 h postfertilization). PM2.5 exposure uniquely caused a 22 h hatching delay, suggesting developmental disruption. Untargeted metabolomics via LC-MS/MS was employed to investigate underlying mechanisms. Principal component analysis revealed distinct clustering by concentration (PC1, PC2) and particle size (PC1, PC3). Volcano plot analysis identified more altered metabolites (>2-fold change, p < 0.05) in PM2.5 versus PM10 at both concentrations. Pathway analysis demonstrated PM2.5 significantly disrupted pantothenate/CoA, retinol, and riboflavin metabolism, indicating these pathways mediate PM2.5-induced effects on embryonic development. At 1000 μg/mL, riboflavin significantly decreased in PM2.5 versus PM10 groups. Glutathione metabolism showed differential responses: reduced glutathione was depleted in PM2.5 but increased in PM10-exposed embryos, suggesting particle size-dependent oxidative stress responses. These findings demonstrate PM2.5 more potently disrupts embryonic metabolic pathways than PM10, potentially informing prevention strategies, including vitamin supplementation for PM-related developmental abnormalities.

